Pablo A. Gaspar
Santiago, RM 8330111, Chile
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Relationship among Sleep Disturbance, Stress, and Suicidal Ideation in Clinical High Risk for Psychosis.
Journal: Schizophrenia bulletin open
Published: December 20, 2025
Processing Speed and Verbal Learning Ability as Predictors of Assessor-Rated and Ecological Momentary Assessment Self-Reported Functioning: Findings from AMP SCZ.
Journal: Schizophrenia bulletin
Published: November 26, 2025
Baseline Clinical Characterization of Participants in the Accelerating Medicines Partnership Schizophrenia Program.
Journal: Schizophrenia bulletin open
Published: August 27, 2025
Sample Ascertainment and Recruitment Sources in the Accelerating Medicines Partnership Schizophrenia Program.
Journal: Schizophrenia bulletin open
Published: August 27, 2025
Premorbid adjustment problems, negative symptoms, and cognitive impairment in a large international sample at clinical high risk for psychosis: Findings from the Accelerating Medicines Partnership-Schizophrenia.
Journal: Schizophrenia bulletin
Published: March 26, 2025
The electroencephalography protocol for the Accelerating Medicines Partnership® Schizophrenia Program: Reliability and stability of measures.
Journal: Schizophrenia (Heidelberg, Germany)
Published: October 29, 2024
Sample ascertainment and clinical outcome measures in the Accelerating Medicines Partnership® Schizophrenia Program.
Journal: Schizophrenia (Heidelberg, Germany)
Published: September 04, 2024
The MR neuroimaging protocol for the Accelerating Medicines Partnership® Schizophrenia Program.
Journal: Schizophrenia (Heidelberg, Germany)
Published: September 02, 2024
Digital health technologies in the accelerating medicines Partnership® Schizophrenia Program.
Journal: Schizophrenia (Heidelberg, Germany)
Published: August 29, 2024
Collecting language, speech acoustics, and facial expression to predict psychosis and other clinical outcomes: strategies from the AMP® SCZ initiative.
Journal: Schizophrenia (Heidelberg, Germany)
Published: August 28, 2024
Cognitive assessment in the Accelerating Medicines Partnership® Schizophrenia Program: harmonization priorities and strategies in a diverse international sample.
Journal: Schizophrenia (Heidelberg, Germany)
Published: August 28, 2024
Imitative inhibitory control is associated with psychotic experiences in a sample from the general population.
Journal: Frontiers in psychiatry
Published: July 24, 2024
Last Updated: 09/26/2026